InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
21
T+90 hit rate
33%
T+90 mean return
-16.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Eaton Bruce, Vice-Président Exécutif, Responsable Commercial. Director active across 1 company, notably Editas Medicine, Inc.. Aggregated, 24 disclosures have been recorded. Split: 0 buy · 21 sells. Total volume traded: €118k. Activity tracked since 9 November 2021. The latest transaction was disclosed on 5 December 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
103 shares@ US$10.89720.8% of flowCommon StockSEC:0001650664-23-000029:0
695 shares@ US$8.20964.0% of flowCommon StockSEC:0001650664-23-000022:0
139 shares@ US$8.400.8% of flowCommon StockSEC:0001650664-23-000019:0
103 shares@ US$8.820.6% of flowCommon StockSEC:0001650664-23-000002:0
702 shares@ US$8.59354.1% of flowCommon StockSEC:0001415889-23-012264:0
141 shares@ US$8.390.8% of flowCommon StockSEC:0001415889-23-012049:0
105 shares@ US$9.5030.7% of flowCommon StockSEC:0001415889-23-009368:0
668 shares@ US$9.8724.5% of flowCommon StockSEC:0001415889-23-007989:0
135 shares@ US$9.510.9% of flowCommon StockSEC:0001415889-23-007816:0
16,700 shares0Common StockSEC:0001415889-23-004312:0
3,307 shares@ US$9.665322.5% of flowCommon StockSEC:0001415889-23-002602:0
346 shares@ US$11.102.7% of flowCommon StockSEC:0001415889-23-002218:0
102 shares@ US$10.230.7% of flowCommon StockSEC:0001415889-22-012131:0
289 shares@ US$11.022.4% of flowCommon StockSEC:0001415889-22-011242:0
101 shares@ US$15.011.2% of flowCommon StockSEC:0001415889-22-009448:0
293 shares@ US$18.59864.0% of flowCommon StockSEC:0001415889-22-008463:0
1,123 shares@ US$11.53690.0060% mcap18.4% of flowCommon StockSEC:0001415889-22-006162:0
297 shares@ US$13.11280.0018% mcap5.6% of flowCommon StockSEC:0001415889-22-004837:0
287 shares@ US$57.170.0070% mcap21.4% of flowCommon StockSEC:0001415889-22-003709:0
403 shares@ US$17.32770.0031% mcap9.6% of flowCommon StockSEC:0001415889-22-002656:0
37,593 shares0Common StockSEC:0001415889-22-001225:0
302 shares@ US$17.62610.0023% mcap7.1% of flowCommon StockSEC:0001415889-22-001195:0
3,472 shares0Common StockSEC:0001179110-21-011227:0
287 shares@ US$40.610.0050% mcap15.4% of flowCommon StockSEC:0001179110-21-010059:0
24 of 24 declarations
About Eaton Bruce
Bruce Eaton is the Executive Vice President and Chief Business Officer at Editas Medicine, Inc. In this role, he oversees business operations and strategy for the company. Bruce is committed to promoting growth and innovation, thereby contributing to Editas's position in the biotechnology market.
